EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Npy transcription is regulated by noncanonical STAT3 signaling in hypothalamic neurons: Implication with lipotoxicity and obesity

Wenyuan He, Neruja Loganathan, Andy Tran, Denise D Belsham

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Wenyuan He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Physiology, University of Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Neuropeptide Y, Leptin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropeptide Y (Npy) is an abundant neuropeptide expressed in the central and peripheral nervous systems. NPY-secreting neurons in the hypothalamic arcuate nucleus regulate energy homeostasis, and Npy mRNA expression is regulated by peripheral nutrient and hormonal signals like leptin, interleukin-6 (IL-6), and fatty acids. This study demonstrates that IL-6, which phosphorylates tyrosine 705 (Y705) of STAT3, decreased Npy mRNA in arcuate immortalized hypothalamic neurons. In parallel, inhibitors of STAT3-Y705 phosphorylation, stattic and cucurbitacin I, robustly upregulated Npy mRNA. Chromatin-immunoprecipitation showed high baseline total STAT3 binding to multiple regulatory regions of the Npy gene, which are decreased by IL-6 exposure. The STAT3-Npy interaction was further examined in obesity-related pathologies. Notably, in four different hypothalamic neuronal models where palmitate potently stimulated Npy mRNA, Socs3, a specific STAT3 activity marker, was downregulated and was negatively correlated with Npy mRNA levels (R2 = 0.40, p T) is located on an upstream enhancer element of NPY, where the variant is predicted to disrupt validated binding of KLF4, a known inhibitory cofactor of STAT3 and downstream effector of leptin signaling. Collectively, this study demonstrates that STAT3 signaling negatively regulates Npy transcription, and that disruption of this interaction may contribute to metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuropeptide YLeptinHumansInterleukin-6HypothalamusObesityArcuate Nucleus of HypothalamusNeuronsRNA, MessengerSTAT3 Transcription Factor

Stichwörter der Autor:innen

HypothalamusIL-6KLF4NPYNeuronObesityPalmitateSNPSTAT3rs17149106

Substanzen

Neuropeptide YLeptinInterleukin-6RNA, MessengerSTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Departments of Physiology, University of Toronto, Ontario, Canada.
  • Departments of Physiology, University of Toronto, Ontario, Canada; Departments of Medicine, University of Toronto, Ontario, Canada. Electronic address: d.belsham@utoronto.ca.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

He, W., Loganathan, N., Tran, A., & Belsham, D. D. (2024). Npy transcription is regulated by noncanonical STAT3 signaling in hypothalamic neurons: Implication with lipotoxicity and obesity. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112179

Vancouver

He W, Loganathan N, Tran A, Belsham DD. Npy transcription is regulated by noncanonical STAT3 signaling in hypothalamic neurons: Implication with lipotoxicity and obesity. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112179

BibTeX
@article{He2024,
  author = {He, Wenyuan and Loganathan, Neruja and Tran, Andy and Belsham, Denise D},
  title = {Npy transcription is regulated by noncanonical STAT3 signaling in hypothalamic neurons: Implication with lipotoxicity and obesity},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112179}
}
Kostenlos starten →